Drug Repurposing for Rare Diseases: A Role for Academia
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.746987
Abstract: Background: The European Commission highlights in its Pharmaceutical Strategy the role of academic researchers in drug repurposing, especially in the development of orphan medicinal products (OMPs). This study summarizes the contribution of academia over the… read more here.
Keywords: diseases role; repurposing rare; rare diseases; drug repurposing ... See more keywords